Dr. Liu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Highland Hospital
HCP 5 GI LAB
Oakland, CA 94602- Is this information wrong?
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Gastroenterology, 2005 - 2009
- University of Michigan Health SystemResidency, Internal Medicine, 2001 - 2004
- University of Texas Medical Branch School of MedicineClass of 2001
Certifications & Licensure
- CA State Medical License 2012 - 2026
- TX State Medical License 2006 - 2013
- MI State Medical License 2001 - 2008
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 13 citationsIntravenous 2-hydroxypropyl-β-cyclodextrin (Trappsol® Cyclo™) demonstrates biological activity and impacts cholesterol metabolism in the central nervous system and per...Caroline Hastings, Benny Liu, Bryan Hurst, Gerald F Cox, Sharon Hrynkow> ;Molecular Genetics and Metabolism. 2022 Dec 1
- 10 citationsRace/Ethnicity-specific Disparities in In-Hospital Mortality and Hospital Charges Among Inflammatory Bowel Disease-related Hospitalizations in the United States.Artin Galoosian, Mona Rezapour, Benny Liu, Taft Bhuket, Robert J. Wong> ;Journal of Clinical Gastroenterology. 2020 Aug 1
- 13 citationsUpdated Assessment of Colorectal Cancer Incidence in the U.S. by Age, Sex, and Race/EthnicityAjay Ohri, Ann Robinson, Benny Liu, Taft Bhuket, Robert J. Wong> ;Digestive Diseases and Sciences. 2020 Jun 1
- Join now to see all
Press Mentions
- Cyclo Therapeutics Announces Positive Efficacy Data from Extension Protocol with Trappsol® Cyclo™ in Patients with Niemann-Pick Disease Type CJanuary 5th, 2021
- Cyclo Therapeutics Inc. Announces Positive Top Line Results from Phase I Trial and Interim Analysis of Phase I/II Trial Using Trappsol® Cyclo™ Intravenously to Treat Patients with Niemann-Pick Disease Type C1 (NPC1)May 20th, 2020
- Last Patient Last Visit in Cyclo Therapeutics’ Phase I Trial in Niemann-Pick Type CFebruary 11th, 2020
- Join now to see all
Hospital Affiliations
- Fairmont HospitalSan Leandro, California
- UCSF Benioff Children's Hospital OaklandOakland, California
- Highland HospitalOakland, California
- UCSF Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: